Steven J. Goulart Sells 14,200 Shares of Metlife Inc (NYSE:MET) Stock

Metlife Inc (NYSE:MET) EVP Steven J. Goulart sold 14,200 shares of the business’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $51.60, for a total value of $732,720.00. Following the completion of the sale, the executive vice president now directly owns 127,130 shares in the company, valued at approximately $6,559,908. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

NYSE MET opened at $52.28 on Friday. The stock has a market capitalization of $48.08 billion, a P/E ratio of 8.64, a P/E/G ratio of 1.19 and a beta of 1.07. Metlife Inc has a 1 year low of $41.41 and a 1 year high of $53.28. The business’s fifty day moving average is $51.45 and its two-hundred day moving average is $48.50. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.15 and a current ratio of 0.14.

Metlife (NYSE:MET) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.98 EPS for the quarter, beating analysts’ consensus estimates of $1.40 by $0.58. The company had revenue of $18.15 billion during the quarter, compared to the consensus estimate of $16.82 billion. Metlife had a return on equity of 9.14% and a net margin of 8.39%. The company’s quarterly revenue was up 17.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.35 EPS. On average, research analysts forecast that Metlife Inc will post 6.1 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, March 13th. Stockholders of record on Tuesday, February 4th will be given a dividend of $0.44 per share. This represents a $1.76 dividend on an annualized basis and a dividend yield of 3.37%. The ex-dividend date is Monday, February 3rd. Metlife’s dividend payout ratio (DPR) is presently 28.81%.

Several analysts have recently weighed in on MET shares. Morgan Stanley upgraded Metlife from an “equal weight” rating to an “overweight” rating and upped their price objective for the company from $55.00 to $60.00 in a report on Tuesday, January 7th. Wells Fargo & Co reaffirmed a “buy” rating on shares of Metlife in a report on Monday, January 6th. ValuEngine raised Metlife from a “strong sell” rating to a “sell” rating in a report on Saturday, December 21st. Credit Suisse Group dropped their price target on shares of Metlife from $63.00 to $60.00 and set an “outperform” rating on the stock in a research report on Monday, February 3rd. Finally, Royal Bank of Canada reissued a “buy” rating and issued a $57.00 price target on shares of Metlife in a report on Sunday, February 9th. Two analysts have rated the stock with a sell rating, five have issued a hold rating and five have given a buy rating to the company. Metlife currently has an average rating of “Hold” and a consensus target price of $52.60.

Institutional investors have recently made changes to their positions in the company. BlackRock Inc. raised its holdings in Metlife by 1.9% during the 2nd quarter. BlackRock Inc. now owns 72,819,515 shares of the financial services provider’s stock worth $3,616,945,000 after buying an additional 1,385,433 shares during the period. FMR LLC boosted its holdings in shares of Metlife by 1.6% in the fourth quarter. FMR LLC now owns 34,976,649 shares of the financial services provider’s stock worth $1,782,760,000 after buying an additional 554,242 shares during the period. Diamond Hill Capital Management Inc. boosted its holdings in shares of Metlife by 0.6% in the third quarter. Diamond Hill Capital Management Inc. now owns 9,991,921 shares of the financial services provider’s stock worth $471,219,000 after buying an additional 57,004 shares during the period. AQR Capital Management LLC increased its position in shares of Metlife by 28.5% in the fourth quarter. AQR Capital Management LLC now owns 8,824,066 shares of the financial services provider’s stock worth $449,586,000 after acquiring an additional 1,959,431 shares in the last quarter. Finally, AJO LP increased its position in shares of Metlife by 26.2% in the fourth quarter. AJO LP now owns 3,682,448 shares of the financial services provider’s stock worth $187,693,000 after acquiring an additional 765,110 shares in the last quarter. 74.45% of the stock is currently owned by institutional investors.

About Metlife

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

Featured Article: FinTech

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.